Teladoc shares tumble on wider-than-expected loss, disappointing revenue guidance

Core Viewpoint - Teladoc Health reported a wider loss than expected and provided disappointing guidance for the upcoming quarter, leading to a decline in its stock price [1][2]. Financial Performance - Revenue decreased by 3% in Q4 to $640.5 million compared to$ 660.5 million in the same period last year [1][6]. - Net loss widened to $48.4 million, or 28 cents per share, from a loss of$ 28.9 million, or 17 cents per share, a year ago [1]. - Adjusted earnings fell by 35% to $74.8 million in Q4, with the Integrated Care segment down 5% to$ 53.2 million and BetterHelp's adjusted earnings dropping 63% to $21.7 million [3]. Future Guidance - For Q1, Teladoc expects revenue between$ 608 million and $629 million, below analysts' expectations of$ 632.9 million [4]. - Adjusted earnings for the first quarter are projected to be between $47 million and$ 59 million [4]. Strategic Moves - Teladoc announced the acquisition of preventative care company Catapult Health for $65 million, which is expected to contribute to future growth [5].